These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24841819)

  • 41. Symptomatic vitreomacular adhesion.
    Jackson TL; Nicod E; Simpson A; Angelis A; Grimaccia F; Kanavos P
    Retina; 2013 Sep; 33(8):1503-11. PubMed ID: 23714857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enzymatic vitreous disruption.
    Gandorfer A
    Eye (Lond); 2008 Oct; 22(10):1273-7. PubMed ID: 18292784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Intravitreal autologous plasmin without associated-vitrectomy. Pharmacological vitreolysis, a perfeccionated method using urokinase].
    Díaz-Llopis M; Udaondo P; Salom D; García-Delpech S; Romero FJ
    Arch Soc Esp Oftalmol; 2008 May; 83(5):291-2. PubMed ID: 18464177
    [No Abstract]   [Full Text] [Related]  

  • 44. [The need for pharmacology in vitreoretinal surgery SOE Lecture 2007].
    Gandorfer A
    Klin Monbl Augenheilkd; 2007 Dec; 224(12):900-4. PubMed ID: 18260053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microplasmin before vitrectomy.
    Narayanan R; Dave V
    Ophthalmology; 2011 Feb; 118(2):428-9; author reply 429. PubMed ID: 21292118
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients.
    Sebag J; Ansari RR; Suh KI
    Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):576-80. PubMed ID: 16941141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Causes and treatment of vitreous hemorrhage.
    Goff MJ; McDonald HR; Johnson RN; Ai E; Jumper JM; Fu AD
    Compr Ophthalmol Update; 2006; 7(3):97-111. PubMed ID: 16882398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microplasmin-assisted vitrectomy.
    Gandorfer A
    Dev Ophthalmol; 2009; 44():26-30. PubMed ID: 19494649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacologic vitreolysis: rationale, potential indications, and promising agents.
    Gandorfer A
    Retina; 2012 Sep; 32 Suppl 2():S221-4. PubMed ID: 22929325
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacovitrectomy.
    Dolz-Marco R; Gallego-Pinazo R; Díaz-Llopis M; Arévalo JF
    Dev Ophthalmol; 2014; 54():126-34. PubMed ID: 25196761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacologic vitreolysis combining the two enzymes plasmin and hyaluronidase.
    Gandorfer A; Kampik A
    Retina; 2005; 25(5):674; author reply 674-5. PubMed ID: 16077373
    [No Abstract]   [Full Text] [Related]  

  • 52. Predictability of vitreous detachment following intravitreal plasmin injection in diabetic macular edema associated with vitreomacular traction.
    Elbendary AM; Elwan MM; Azzam HA; Eldeeb DR
    Curr Eye Res; 2011 Jun; 36(6):534-9. PubMed ID: 21591862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacological vitreolysis].
    Haritoglou C; Kampik A
    Ophthalmologe; 2013 Oct; 110(10):935-40. PubMed ID: 24046166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of vitreomacular adhesion on ranibizumab mono- and combination therapy for neovascular age-related macular degeneration.
    Waldstein SM; Ritter M; Simader C; Mayr-Sponer U; Kundi M; Schmidt-Erfurth U
    Am J Ophthalmol; 2014 Aug; 158(2):328-336.e1. PubMed ID: 24794282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ocriplasmin for symptomatic vitreomacular adhesion.
    Blue Cross and Blue Shield Association
    Technol Eval Cent Assess Program Exec Summ; 2013 Aug; 28(5):1-3. PubMed ID: 24066370
    [No Abstract]   [Full Text] [Related]  

  • 56. Vitreomacular traction and exudative age-related macular degeneration.
    Schulze S; Hoerle S; Mennel S; Kroll P
    Acta Ophthalmol; 2008 Aug; 86(5):470-81. PubMed ID: 18537930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pharmacologic vitreolysis in diabetic rats].
    Luo M; Wang ZL; Shi WD; Fan XQ; Xu GT
    Zhonghua Yan Ke Za Zhi; 2009 May; 45(5):417-23. PubMed ID: 19576064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitreoretinal disease in the coming decade.
    Chiang A; Haller JA
    Curr Opin Ophthalmol; 2010 May; 21(3):197-202. PubMed ID: 20224401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pneumatic vitreolysis for symptomatic vitreomacular traction: case report.
    Hernandez Bel L; Cervera Taulet E; Castro Navarro V; Montero Hernández J; Navarro Palop C; Chiarri Toumet C
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Jan; 93(1):e1-e2. PubMed ID: 28728952
    [No Abstract]   [Full Text] [Related]  

  • 60. Ocriplasmin: a medical or surgical therapy?
    Duker JS; Moshfeghi AA
    Retina; 2013; 33(10):2001-2. PubMed ID: 24113274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.